HIGHLIGHTS
- who: Jie Deng from the Peking University People`s Hospital, China have published the Article: CXCL5: A coachman to drive cancer progression, in the Journal: (JOURNAL)
- what: Searching for new potential prognostic biomarkers has always been one of the main focuses in oncology.
- how: All these data indicated that CXCL5 might activate EMT Frontiers in Oncology Mechanism of CXCL5 for promoting tumor progression Tumor angiogenesis Tumor angiogenesis is essential during malignant tumor progression. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.